Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|August 28, 2016
Quantification of PD-L1 and PD-1 expression on tumor and immune cells in non-small cell lung cancer (NSCLC) using non-enzymatic tissue dissociation and flow cytometryAmanda Chargin, Rian Morgan, Uma Sundram, et al.Cell|January 22, 2013
The ciliary G-protein-coupled receptor Gpr161 negatively regulates the Sonic hedgehog pathway via cAMP signalingSaikat Mukhopadhyay, Xiaohui Wen, Navneet Ratti, et al.Histopathology|March 6, 2012
Neuropilin-2 expression in cancerAdrian M Jubb, Susan M Sa, Navneet Ratti, et al.Science Translational Medicine|December 22, 2021
An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphomaPaul-Joseph Aspuria, Sandro Vivona, Michele Bauer, et al.Investigational New Drugs|September 10, 2020
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC)J Randolph Hecht, Kyriakos P Papadopoulos, Gerald S Falchook, et al.Plos One|January 11, 2014
Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk alleleSteven E Kauder, Lydia Santell, Elaine Mai, et al.The Lancet. Oncology|September 30, 2019
Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trialAung Naing, Deborah J Wong, Jeffrey R Infante, et al.Cell Reports|December 20, 2025
An IL-12 partial agonist sustains intratumoral lymphocyte activation and detoxifies systemic IL-12 therapyIevgen Koliesnik, Michael Totagrande, Bhargavi Jayaraman, et al.Frontiers in Immunology|September 26, 2019
Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and CancerWeiYu Lin, Daqi Xu, Cary D Austin, et al.Pageof 1